Ligand validation:6C3I

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6C3I designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6C3I_OLC_A_501	11%	55%	0.292	0.813	0.82	0.93	2	1	2	0	100%	1
6C3I_OLC_B_502	7%	54%	0.339	0.801	0.81	0.95	2	1	3	0	100%	1
6C3I_OLC_A_503	6%	48%	0.324	0.806	0.96	1.05	2	1	1	0	72%	1
6C3I_OLC_A_502	4%	52%	0.353	0.771	0.9	0.94	2	1	1	0	80%	1
6C3I_OLC_A_504	2%	55%	0.531	0.801	0.81	0.91	2	1	1	0	100%	1
6C3I_OLC_B_501	2%	55%	0.539	0.794	0.81	0.94	2	1	0	0	100%	1
8E6N_OLC_A_510	31%	71%	0.129	0.91	0.29	0.8	-	-	1	0	36%	1
8E5V_OLC_A_506	30%	49%	0.167	0.881	0.95	1.03	2	1	0	0	72%	1
8E6L_OLC_A_504	27%	50%	0.222	0.903	0.89	1.04	2	1	2	0	80%	1
6D91_OLC_A_504	23%	37%	0.17	0.878	1.09	1.39	2	1	2	0	52%	1
8E6M_OLC_A_510	23%	54%	0.2	0.819	0.81	0.98	1	1	5	0	100%	1
9F9J_OLC_A_307	100%	42%	0.034	0.981	1.05	1.18	1	2	0	0	100%	1
7YXA_OLC_A_2505	70%	60%	0.127	0.943	0.67	0.84	-	-	3	0	100%	1
9F9D_OLC_A_308	67%	42%	0.081	0.887	0.96	1.29	1	3	0	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	4	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.